Insulin-independent diabetes mellitus.
D000092:Acetohexamide / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000368:Aged; D001485:Basement Membrane / Q000473:pathology; D002196:Capillaries / Q000473:pathology; D002239:Carbohydrate Metabolism, Inborn Errors / Q000175:diagnosis; D002747:Chlorpropamide / Q000627:therapeutic use; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D003927:Diet, Diabetic; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology; D007004:Hypoglycemic Agents / Q000009:adverse effects; D007239:Infections / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000473:pathology; D009765:Obesity / Q000150:complications; D010629:Phenformin / Q000627:therapeutic use; D012883:Skin Ulcer / Q000209:etiology; D013848:Thigh; D014042:Tolazamide / Q000627:therapeutic use; D014044:Tolbutamide / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D014044:Tolbutamide; D014042:Tolazamide; D010629:Phenformin; D000092:Acetohexamide; D002747:Chlorpropamide